UBS 1Q adjusted profit before tax CHF 1.4 billion

  • Net profit attributable to UBS Group AG shareholders CHF 707 million; diluted earnings per share CHF 0.18
  • Fully applied CET1 capital ratio 14.0%; Swiss SRB fully applied leverage ratio 5.4%
  • UBS raises record USD 471 million Oncology Impact Fund to develop cancer treatments